Loading...
Diabetes and gout: efficacy and safety of febuxostat and allopurinol
Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...
Na minha lista:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Blackwell Publishing Ltd
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/ https://ncbi.nlm.nih.gov/pubmed/23683134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|